Skip to content
Delayed ~15 min

ENTA ENANTA PHARMACEUTICALS INC

Permanent stock page ↗

Health Care · Russell 2000

Next earnings: Mon 16 Nov 2026 · estimated

What 8 analyst firms say about ENANTA PHARMACEUTICALS INC: their latest ratings, price targets and how far the stock is from them. How it works

11.00 USD+0.92 (+9.13%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+77.3%to the avg target 19.50 USD+8.50 USD
Buy 6 · Hold 1 · Sell 0

7 rated views · 8 analyst/firm records · 8 firms

Latest report23 Sep 2026avg report date 27 Apr
Target rangePrice is below every target

Radar score

  • Russell 2000 · Top Picks · 6MNot scored · Fewer than 4 price targets in the last 6 months (3)
  • Russell 2000 · Safest consensus · 6MNot scored · Fewer than 4 price targets in the last 6 months (3)

Recent analyst activity · last 90 days

Our tracked history has 3 reports on ENTA from 2 analyst firms in the last 90 days (8 firms in the past year).

Comparing each firm's latest target with its previous one: 1 left it unchanged.

No firm's latest available rating differs from its previous one.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
BairdBrian P SkorneyBuy18 Jun 202620.00 USD
Evercore ISIJonathan MillerBuy13 Feb 202620.00 USD
H.C. WainwrightBrandon FolkesBuy23 Sep 202620.00 USD
JefferiesAkash TewariBuy1 Jul 202620.00 USD
JPMorganAnupam RamaBuy14 Nov 202517.00 USD
Rodman & RenshawSeema SheoranBuy26 Mar 202620.00 USD
Weiss RatingsUnnamed analyst—15 Oct 2026—
Data feed RESEARCHResearch TeamHold15 Jun 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 07:00 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.